Foldable glued-IOL procedure successful

Article

The foldable glued-IOL technique provides satisfactory and safe visual outcomes, claims a paper in the latest issue of the Journal of Cataract and refractive Surgery.

The foldable glued-IOL technique provides satisfactory and safe visual outcomes, claims a paper in the latest issue of the Journal of Cataract and refractive Surgery.

Dr Amar Agarwal et al., Dr Agarwal's Eye Hospital and Eye Research Centre, Chennai, India, studied 208 eyes of 185 patients who received a primary glued foldable IOL for intraoperative capsular loss or subluxated lens or secondary glued foldable IOL for aphakia.

The exclusion criteria included preoperative glaucoma, aniridia, macular scar, traumatic subluxation, combined surgeries, incomplete operative medical records and a postoperative follow-up of less than six months. Among the outcome measures were intraoperative and postoperative complication rates, reoperation rate and visual outcomes were analysed.

Intraoperative complications presented were hyphaema, haptic breakage and deformed haptics in 0.4%, 0.4% and 0.9% of patients, respectively. There were early complications in 13.9% of eyes, including corneal oedema, epithelial defect and grade two anterior chamber reaction.

The late complications occurred in 18.7% of eyes and included optic capture, IOL decentration, haptic extrusion, subconjunctival haptic, macular oedema and pigment dispersion.

The group discovered that reoperation was required in 7.7% of eyes and haptic position was altered in eyes with IOL decentration. Corrected distance visual acuity was 20/40 or better in 38.9% of eyes and 20/60 or better in 48.5% of eyes. IOL decentration was caused by haptic-related issues.

For more details on the study please click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.